Pacira Pharmaceuticals Dividends
| PCRX Stock | USD 25.90 0.91 3.39% |
At this time, Pacira Pharmaceuticals' Dividends Paid is fairly stable compared to the past year. Dividend Payout Ratio is likely to rise to 0.06 in 2024, whereas Dividend Yield is likely to drop 0 in 2024. Pacira Pharmaceuticals' past performance could be the main factor of why investors trade Pacira Pharmaceuticals stock today. Investors should clearly understand every aspect of the Pacira Pharmaceuticals dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Pacira Pharmaceuticals' dividend schedule and payout information. Pacira Pharmaceuticals dividends can also provide a clue to the current valuation of Pacira Pharmaceuticals.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 3.2 M | 3.4 M | |
| Dividend Yield | 0 | 0 | |
| Dividend Payout Ratio | 0.06 | 0.06 | |
| Dividend Paid And Capex Coverage Ratio | (12.52) | (11.90) |
Pacira |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Pacira Pharmaceuticals must own a stock before its ex-dividend date to receive its next dividend.
Pacira Pharmaceuticals Dividends Paid Over Time
Today, most investors in Pacira Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Pacira Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Pacira Pharmaceuticals dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Pacira Pharmaceuticals Historical Dividend Yield Growth
A solid dividend growth pattern of Pacira Pharmaceuticals could indicate future dividend growth is likely, which can signal long-term profitability for Pacira Pharmaceuticals. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Pacira Pharmaceuticals dividend as a percentage of Pacira Pharmaceuticals stock price. Pacira Pharmaceuticals dividend yield is a measure of Pacira Pharmaceuticals stock productivity, which can be interpreted as interest rate earned on an Pacira Pharmaceuticals investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Is Pacira Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacira Pharmaceuticals. If investors know Pacira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacira Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.291 | Earnings Share 0.89 | Revenue Per Share 14.603 | Quarterly Revenue Growth 0.054 | Return On Assets 0.0335 |
The market value of Pacira Pharmaceuticals is measured differently than its book value, which is the value of Pacira that is recorded on the company's balance sheet. Investors also form their own opinion of Pacira Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Pacira Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacira Pharmaceuticals' market value can be influenced by many factors that don't directly affect Pacira Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacira Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacira Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacira Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.